Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Associate Partners:

  • Kotak Mutual Fund
  • Pharmeasy
  • Indiabulls
  • State Bank of India
  • CoinSwitch Kuber

Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Technology Partner

Dell Technologies

Associate Partners

Kotak Mutual Fund
Pharmeasy
Indiabulls
State Bank of India
CoinSwitch Kuber
you are here:

Fresenius Kabi Oncology Ltd.

BSE: 532545 | NSE: FKONCO | Series: NA | ISIN: INE575G01010 | SECTOR: Pharmaceuticals

BSE Live

Jan 02, 15:50
132.45 0.00 (0.00%)
Volume
No Data Available
91,518
  • Prev. Close

    132.45

  • Open Price

    132.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    132.45 (20430)

Fresenius Kabi Oncology is not traded on BSE in the last 30 days

NSE Live

Oct 13, 12:25
1035.00 0.00 (0.00%)
Volume
No Data Available
119
  • Prev. Close

    1035.00

  • Open Price

    1030.60

  • Bid Price (Qty.)

    1033.85 (729)

  • Offer Price (Qty.)

    1035.90 (652)

Fresenius Kabi Oncology is not traded on NSE in the last 30 days

Financials

2021 2020 2019 2018 2017
Quarterly Results of Fresenius Kabi Oncology (in Rs. Cr.) Dec '13 Sep '13 Jun '13 Mar '13 Dec '12  
Net Sales/Income from operations 45.27 81.56 80.95 70.54 150.38  
Other Operating Income 39.39 14.58 45.92 22.69 54.66  
Total Income From Operations 84.66 96.15 126.87 93.24 205.04  
EXPENDITURE  
Consumption of Raw Materials 53.88 35.05 35.59 51.55 29.05  
Purchase of Traded Goods 2.75 1.95 0.24 1.48 1.52  
Increase/Decrease in Stocks -25.72 -7.67 1.15 -34.52 18.83  
Power & Fuel -- -- -- -- --  
Employees Cost 20.29 20.37 15.21 17.41 17.16  
depreciat 8.34 7.53 6.91 6.53 6.69  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses 34.92 12.20 37.84 9.26 47.95  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 35.27 63.13 28.35 36.71 29.24  
P/L Before Other Inc. , Int., Excpt. Items & Tax -45.06 -36.42 1.57 4.82 54.61  
Other Income 6.20 0.00 0.86 0.82 --  
P/L Before Int., Excpt. Items & Tax -38.86 -36.41 2.43 5.64 54.61  
Interest 9.94 7.32 -4.68 -2.07 -7.73  
P/L Before Exceptional Items & Tax -48.80 -43.73 7.11 7.71 62.34  
Exceptional Items -- -- -- -- --  
P/L Before Tax -48.80 -43.73 7.11 7.71 62.34  
Tax 2.38 1.06 2.31 8.66 13.99  
P/L After Tax from Ordinary Activities -51.18 -44.79 4.80 -0.95 48.36  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -12.44 -- -- -6.81 --  
Net Profit/(Loss) For the Period -63.63 -44.79 4.80 -7.76 48.36  
Equity Share Capital 15.82 15.82 15.82 15.82 15.82  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS -3.23 -2.83 0.30 -0.06 3.06  
Diluted EPS -3.23 -2.83 0.30 -0.06 3.06  
EPS After Extra Ordinary  
Basic EPS. -4.02 -2.83 0.30 -0.49 3.06  
Diluted EPS. -4.02 -2.83 0.30 -0.49 3.06  
Public Share Holding  
No Of Shares (Crores) 1.32 3.01 3.01 3.01 3.01  
Share Holding (%) 8.31 19.00 19.00 19.00 19.00  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). 14.51 12.82 12.82 1.28 12.82  
- Per. of shares (as a % of the total sh. of prom. and promoter group). 100.00 100.00 100.00 100.00 100.00  
- Per. of shares (as a % of the total Share Cap. of the company). 91.69 81.00 81.00 81.00 81.00  
Source : Dion Global Solutions Limited